Endocrine Abstracts

Background: Over the last year the social consequences of obesity has become significant, with weight-based stigmatization and prejudiced common outcomes. Toxic hepatitis is one of those diseases that has obese as comorbidity in different age groups. The pervasiveness of prejudice toward obese in patients with toxic hepatitis makes it imperative that scientists have access to valid and reliable measures to assess weight bias.Objectives: Age groups struct...

Toxic hepatitis is a diffuse inflammatory process in the liver which is caused by the impact of industrial poisons of hepatotoxic action in doses exceeding the maximum allowable concentration. Given the complexity of differentiation, in fact, the symptoms of the disease from possible side effects of treatment, the statistics of the prevalence of the disease in this profile is quite ambiguous. Data from clinical studies show that in the structure of acute and chronic liver dise...

BackgroundOver the last years obesity has become an important medical and social problem in almost all countries of the world. The social significance of the problem is determined by the disability threat of patients and reduction of overall life expectancy due to the frequent comorbidities development. According to scientific data and modern ideas, there are a number of factors that affect not only the course of toxic hepatitis, but also the therapy eff...

Drug-induced liver injury (DILI) today is a global problem in modern gastroenterology and is increasingly common worldwide, demanding focused attention and in-depth study, particularly in terms of recognizing the major clinical syndromes. These often complicate the course of DILI and as a result, its correction.Objective: To investigate the frequency of major clinical syndromes in patients with DILI during chemotherapy with normal and excess body weight....